Article: Artificial intelligence, molecular subtyping, biomarkers, and precision oncology.
Emerging topics in life sciences
2021 Volume 5, Issue 6, Page(s) 747–756
Abstract: A targeted cancer therapy is only useful if there is a way to accurately identify the tumors that are susceptible to that therapy. Thus rapid expansion in the number of available targeted cancer treatments has been accompanied by a robust effort to ... ...
Abstract | A targeted cancer therapy is only useful if there is a way to accurately identify the tumors that are susceptible to that therapy. Thus rapid expansion in the number of available targeted cancer treatments has been accompanied by a robust effort to subdivide the traditional histological and anatomical tumor classifications into molecularly defined subtypes. This review highlights the history of the paired evolution of targeted therapies and biomarkers, reviews currently used methods for subtype identification, and discusses challenges to the implementation of precision oncology as well as possible solutions. |
---|---|
MeSH term(s) | Artificial Intelligence ; Biomarkers ; Humans ; Medical Oncology/methods ; Neoplasms/diagnosis ; Neoplasms/pathology ; Neoplasms/therapy ; Precision Medicine/methods |
Chemical Substances | Biomarkers |
Language | English |
Publishing date | 2021-12-09 |
Publishing country | England |
Document type | Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't ; Research Support, U.S. Gov't, Non-P.H.S. ; Review |
ZDB-ID | 2882721-1 |
ISSN | 2397-8554 ; 2397-8554 ; 2397-8562 |
ISSN (online) | 2397-8554 |
ISSN | 2397-8554 ; 2397-8562 |
DOI | 10.1042/ETLS20210212 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.